Head-to-head · Cost-Efficiency Index
TRT Kingdom vs BeyondMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TRT Kingdom
Shoppers open to a TRT-focused telehealth brand's GLP-1 line who are comfortable committing to a 4-month prepay term for the advertised rate.
Visit TRT KingdomBeyondMD
Shoppers who want a named clinical team on a broader wellness platform, not just a single-purpose GLP-1 funnel.
Visit BeyondMDThe verdict
TRT Kingdom takes it, leading the Cost-Efficiency Index 54 to 53. TRT Kingdom -- despite its testosterone-focused name -- runs a genuine compounded GLP-1 weight-loss line ('Compounded GLP-1' and 'Compounded GLP-1/GIP') priced at $149/month and $199/month respectively. BeyondMD still earns a C — Shoppers who want a named clinical team on a broader wellness platform, not just a single-purpose GLP-1 funnel.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TRT Kingdom.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TRT Kingdom | BeyondMD |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 53/100 |
| Semaglutide / mo | $149/mo (compounded) | $125/mo (starting dose, compounded) |
| Tirzepatide / mo | $199/mo (compounded) | $199/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,500 |
| Tirzepatide / yr (modeled) | $2,388 | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #365 | #370 |
TRT Kingdom
54/100Where the value is
- Confirmed, real compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) products exist and are separately priced, despite the company's TRT-focused branding
- Named clinical group and Chief Medical Officer (REM Health Medical Group, P.A.; Daniel Olivero) plus two named nurse practitioners
- LegitScript verification badge displayed
The tradeoffs
- The advertised $149/$199 monthly rates require committing to a 4-month plan; no month-to-month or shorter-term price is published
- Pharmacy is described only as 'an FDA registered pharmacy in the USA' -- no name, state, or accreditation given
BeyondMD
53/100Where the value is
- Individually named clinicians appear on the site rather than only a corporate entity: John Marley Bernard Jr., MD; Hollie Ann Hall, APRN-C; Jordan Dorsey, NP
- LegitScript-certified with the verification seal displayed
- All 50 states served per the site's own claim
The tradeoffs
- The site's own pages disagree with themselves on the tirzepatide starting price — one page says '$199,' another says '$209' — neither dated nor reconciled anywhere public
- No compounding pharmacy is named, only generic 'fully licensed U.S. 503A pharmacies' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.